RCS - Accrol Group Hldgs - Online HY 21 Investor Presentation

Accrol groupAnnouncement

07/01/2021 07:01

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210107:nRSG7896Ka&default-theme=true

RNS Number : 7896K  Accrol Group Holdings PLC  07 January 2021

RNS Reach

 

7 January 2021

 

ACCROL GROUP HOLDINGS PLC
("Accrol" or the "Group")

AIM: ACRL

 

Online HY 21 Investor Presentation

 

The Board of Accrol is pleased to announce that, as part of the Group's Half
Yearly Results roadshow, the management will host an online investor
presentation and Q&A session. This will take place on Friday, 15 January
2021 at 1.15pm. Anyone wishing to participate should register for the event
with PI World at: http://bit.ly/ACRL_H1_webinar
(http://bit.ly/ACRL_H1_webinar) .

 

 For further information, please contact:

 Accrol Group Holdings plc
 Dan Wright, Executive Chairman                           Via Belvedere Communications
 Gareth Jenkins, Chief Executive Officer

 Zeus Capital Limited (Nominated Adviser & Broker)
 Dan Bate / Jordan Warburton                              Tel: +44 (0) 161 831 1512
 Dominic King / John Goold                                Tel: +44 (0) 203 829 5000

 Liberum Capital Limited (Joint Broker)                   Tel: +44 (0) 20 3100 2222
 Clayton Bush / Edward Thomas

 Belvedere Communications Limited
 Cat Valentine                                            Tel: +44 (0) 7715 769 078
 Keeley Clarke                                            Tel: +44 (0) 7967 816 525
 Llew Angus                                               Tel:  +44 (0) 7407 023 147
                                                          accrolpr@belvederepr.com

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet
tissues, kitchen rolls and facial tissues to many of the UK's leading
discounters and grocery retailers across the UK. Following the recent
acquisition of a state-of-the-art tissue converter based in Leicester, the
Group now operates from five sites, including four in Lancashire, which
generate revenues totalling c.16% of the £1.7bn UK retail tissue market.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRADKABQDBKDNDK